Free Trial

Viking Therapeutics (VKTX) Earnings Date, Estimates & Call Transcripts

Viking Therapeutics logo
$27.57 -0.26 (-0.93%)
Closing price 06/9/2025 04:00 PM Eastern
Extended Trading
$27.58 +0.02 (+0.05%)
As of 06/9/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Viking Therapeutics Earnings Summary

Viking Therapeutics issued Q1 2025 earnings on April 23, 2025, reporting an EPS of -$0.41, which missed the consensus estimate of -$0.31 by $0.10. Its revenue was up .0% compared to the same quarter last year. With a trailing EPS of -$1.15, Viking Therapeutics' earnings are expected to decrease next year, from ($1.56) to ($2.07) per share.

Upcoming Q2
Earnings Date
Jul. 23After Market ClosesEstimated
Consensus EPS
(Apr. 23)
-$0.31
Actual EPS
(Apr. 23)
-$0.41 Missed By -$0.10

Q1 2025 Earnings Resources

VKTX Upcoming Earnings

Viking Therapeutics' next earnings date is estimated for Wednesday, July 23, 2025, based on past reporting schedules.

Get Viking Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Viking Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

VKTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Viking Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20254-$0.35-$0.26-$0.31
Q2 20254-$0.45-$0.42-$0.44
Q3 20254-$0.49-$0.45-$0.47
Q4 20254-$0.52-$0.47-$0.49
FY 2025 16 -$1.81 -$1.60 -$1.70
Q1 20261-$0.54-$0.54-$0.54
Q2 20261-$0.55-$0.55-$0.55
Q3 20261-$0.56-$0.56-$0.56
Q4 20261-$0.57-$0.57-$0.57

Viking Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/23/2025
(Estimated)
--------
4/23/2025Q1 2025-$0.31-$0.41 -$0.10-$0.41--
2/5/2025Q4 2024-$0.27-$0.32 -$0.05-$0.32--
10/23/2024Q3 2024-$0.24-$0.22+$0.02-$0.22--
7/24/2024Q2 2024-$0.26-$0.20+$0.06-$0.20--
4/24/2024Q1 2024-$0.27-$0.26+$0.01-$0.26--
2/7/2024Q4 2023-$0.25-$0.25--$0.25--
10/25/2023Q3 2023-$0.22-$0.23 -$0.01-$0.23--
7/26/2023Q2 2023-$0.21-$0.19+$0.02-$0.19--

Viking Therapeutics Earnings - Frequently Asked Questions

Viking Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 23rd, 2025 based off last year's report dates. Learn more on VKTX's earnings history.

In the previous quarter, Viking Therapeutics (NASDAQ:VKTX) missed the analysts' consensus estimate of ($0.31) by $0.10 with a reported earnings per share (EPS) of ($0.41). Learn more on analysts' earnings estimate vs. VKTX's actual earnings.

The conference call for Viking Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Viking Therapeutics's latest earnings report can be read online.
Read Transcript

Viking Therapeutics (NASDAQ:VKTX) has a recorded net income of -$109.96 million. VKTX has generated -$1.15 earnings per share over the last four quarters.

Viking Therapeutics's earnings are expected to decrease from ($1.56) per share to ($2.07) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:VKTX) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners